Clinical Leader Live: In-House Vs. Outsource: Considerations For Biotechs

Laurie Halloran, President & CEO, Halloran Consulting, joined Clinical Leader for an interactive presentation and Q&A session exploring what every small to mid-sized pharma and biotech company should consider when evaluating their outsourcing plan. During this call, Laurie discussed:

• If your outsourcing strategy isn’t working, what should you do?
• How are you building your internal capabilities to enable programs that facilitate longer term program support?
• What new approaches are you engaging to enable data-driven innovation to play a role in supporting more efficient drug development?
• Is your current outsourcing operating model too rigid to experiment with the cutting-edge technology when its efficiency drives margins down for the CROs?